Hedge Fund - Rhenman & Partners Asset Management
Regeneron Pharmaceuticals Inc. (REGN)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $20,136,803 | 2.31% | 31,750 | $687.82 |
| 2 | 2024 - Q4 (2024-12-31) | $30,955,725 | 3.18% | 43,457 | $839.22 |
| 3 | 2024 - Q3 (2024-09-30) | $40,998,360 | 3.32% | 39,000 | $1112.86 |
| 4 | 2024 - Q2 (2024-06-30) | $33,632,960 | 3.22% | 32,000 | $969.40 |
| 5 | 2024 - Q1 (2024-03-31) | $33,013,407 | 3.12% | 34,300 | $950.88 |
| 6 | 2023 - Q4 (2023-12-31) | $34,253,310 | 3.42% | 39,000 | $823.50 |
| 7 | 2023 - Q3 (2023-09-30) | $32,918,400 | 3.54% | 40,000 | $785.91 |
| 8 | 2023 - Q2 (2023-06-30) | $25,148,900 | 2.65% | 35,000 | $771.00 |
| 9 | 2023 - Q1 (2023-03-31) | $28,808,250 | 3.16% | 35,500 | $754.21 |
| 10 | 2022 - Q4 (2022-12-31) | $26,695,130 | 2.78% | 37,000 | $737.86 |
| 11 | 2022 - Q3 (2022-09-30) | $23,960,000 | 2.5% | 32,000 | $629.39 |
| 12 | 2022 - Q2 (2022-06-30) | $8,276,000 | 0.94% | 14,000 | $650.01 |
| 13 | 2022 - Q1 (2022-03-31) | $19,905,000 | 1.96% | 28,500 | $632.65 |
| 14 | 2021 - Q3 (2021-09-30) | $0 | 0% | 0 | $620.82 |
| 15 | 2021 - Q2 (2021-06-30) | $13,964,000 | 0.94% | 25,000 | $506.62 |
| 16 | 2021 - Q1 (2021-03-31) | $9,463,000 | 0.65% | 20,000 | $486.87 |
| 17 | 2020 - Q4 (2020-12-31) | $19,324,000 | 1.57% | 40,000 | $539.80 |
| 18 | 2020 - Q3 (2020-09-30) | $12,595,000 | 1.11% | 22,500 | $606.33 |
| 19 | 2020 - Q2 (2020-06-30) | $7,796,000 | 0.84% | 12,500 | $567.62 |
| 20 | 2020 - Q1 (2020-03-31) | $0 | 0% | 0 | $412.49 |
| 21 | 2019 - Q4 (2019-12-31) | $10,138,000 | 1.11% | 27,000 | $336.44 |
| 22 | 2019 - Q3 (2019-09-30) | $12,492,000 | 1.56% | 45,031 | $295.91 |
| 23 | 2019 - Q2 (2019-06-30) | $14,089,000 | 1.55% | 45,014 | $332.92 |
| 24 | 2018 - Q4 (2018-12-31) | $6,350,000 | 0.72% | 17,000 | $366.02 |
| 25 | 2018 - Q3 (2018-09-30) | $6,869,000 | 0.68% | 17,000 | $380.58 |
| 26 | 2018 - Q2 (2018-06-30) | $5,865,000 | 0.6% | 17,000 | $312.75 |
| 27 | 2018 - Q1 (2018-03-31) | $11,708,000 | 1.44% | 34,000 | $347.81 |
| 28 | 2017 - Q4 (2017-12-31) | $11,713,000 | 1.58% | 31,154 | $405.00 |
| 29 | 2017 - Q3 (2017-09-30) | $9,837,000 | 1.25% | 22,000 | $475.84 |
| 30 | 2017 - Q2 (2017-06-30) | $7,416,000 | 1.06% | 15,100 | $437.61 |
| 31 | 2017 - Q1 (2017-03-31) | $14,338,000 | 2.27% | 37,000 | $370.66 |
| 32 | 2016 - Q4 (2016-12-31) | $9,728,000 | 1.86% | 26,500 | $380.27 |
| 33 | 2016 - Q3 (2016-09-30) | $11,859,590,000 | 1.88% | 29,500 | $401.14 |
| 34 | 2016 - Q2 (2016-06-30) | $17,287,000 | 3.06% | 49,500 | $385.12 |
| 35 | 2016 - Q1 (2016-03-31) | $4,325,000 | 0.85% | 12,000 | $412.07 |
| 36 | 2015 - Q4 (2015-12-31) | $11,400,000 | 1.72% | 21,000 | $541.81 |
The displayed share prices are average quarterly stock market prices.